S-3 424B5 EX-FILING FEES 333-295560 0001676725 IDEAYA Biosciences, Inc. N/A N/A The prospectus is not a final prospectus for the related offering. 0001676725 2026-05-05 2026-05-05 0001676725 1 2026-05-05 2026-05-05 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

IDEAYA Biosciences, Inc.

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities 1 Equity Common Stock, $0.0001 par value per share 415(a)(6) $ 156,552,996.81 S-3 333-272936 06/26/2023 $ 23,107.22

Total Offering Amounts:

$ 156,552,996.81

$ 0.00

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 0.00

Offering Note

1

IDEAYA Biosciences, Inc. (the "Company") previously registered the offer and sale of shares of common stock having an aggregate offering price of up to $350,000,000 by means of a prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act on January 19, 2024 (the "2024 ATM Prospectus Supplement"), pursuant to IDEAYA Biosciences, Inc.'s registration statement on Form S-3ASR (File No. 333-272936) filed with the Securities and Exchange Commission on June 26, 2023 (the "Prior Registration Statement"). In connection with the filing of the 2024 ATM Prospectus Supplement, the Company paid a filing fee of $51,660.00 in connection with the registration of shares of common stock having a maximum aggregate offering price of $350,000,000 to be issued and sold as part of an "at-the-market" offering. Of those shares of common stock, shares having an aggregate sales price of $193,447,003.19 have been sold and shares of common stock with a maximum aggregate offering price of $156,552,996.81 remain unsold (the "Carry Forward Securities"). Pursuant to Rule 415(a)(6) under the Securities Act, the securities registered pursuant to this registration statement include the Carry Forward Securities, and the registration fees totaling $23,107.22 that were previously paid on January 19, 2024 with respect to the Carry Forward Securities will continue to be applied to the Carry Forward Securities. Pursuant to Rule 415(a)(6), the offering of the Carry Forward Securities under the Prior Registration Statement is deemed terminated as of the effective date of this registration statement.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims
Fee Offset Sources
Rule 457(p)
Fee Offset Claims
Fee Offset Sources
Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date